Mesenchymal Cell Survival Signalling by TGF-B1
TGF-B1 的间充质细胞存活信号传导
基本信息
- 批准号:7267645
- 负责人:
- 金额:$ 13.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-05 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Abnormal Epithelial CellAdhesionsAnoikisApoptosisApoptoticCell Differentiation processCell SurvivalCellsCicatrixCollagenDataDevelopmentDiseaseEpithelial CellsExtracellular MatrixFailureFibroblastsFibronectinsFibrosisFosteringGoalsGrantGrowthGrowth FactorHumanIn VitroLaboratoriesLungLung diseasesMediatingMediator of activation proteinMentorshipMesenchymalModelingMolecularMusMyofibroblastPTK2 genePathogenesisPathologicPhenotypePhysiciansPhysiologicalPreventionProcessProtein-Serine-Threonine KinasesPulmonary FibrosisReceptor Protein-Tyrosine KinasesRegulationResearchResearch PersonnelRoleScientistSignal PathwaySignal TransductionTissuesTraining ProgramsTumor Suppressor ProteinsWound Healingautocrinebody systemcareercell injurycell typecytokinedesignextracellularhuman TGFB1 proteinin vivoinsightknowledge baseprogramsrepairedresponseresponse to injuryskills
项目摘要
DESCRIPTION (provided by applicant):
This grant proposes a five year training program designed to foster the development of an independent investigative career as a physician-scientist. The goals of this plan, in addition to completing the research summarized below, are to provide the mentorship, technical skills, laboratory management skills, and knowledge base necessary for academic independence. Pulmonary fibrosis is progressive, debilitating process for which no effective therapy exists. The pathogenesis of fibrotic disease involves a dysfunctional repair response characterized by epithelial cell injury associated with heightened myofibroblast activity. Fibroblast/myofibroblast apoptosis is a crucial component of normal wound healing and failure of fibroblasts to undergo apoptosis results in pathologic scar formation and tissue fibrosis. The mechanisms promoting an anti-apoptotic mesenchymal cell phenotype in fibrotic disease remain unclear. Transforming growth factor-beta 1 (TGF-beta1) is a multifunctional cytokine that acts in a cell-type and context-specific manner. Through stimulation of mesenchymal cell differentiation, activation, and survival, TGF-beta1 is central to the pathogenesis of fibrotic disease in most organ systems. We hypothesize that TGF-beta1 contributes to the pathogenesis of fibrotic disease by promoting an anti-apoptotic phenotype in human lung mesenchymal cells. We propose to examine the mechanisms through which TGF-beta1 protects mesenchymal cells from apoptosis using a combination of in vitro studies to define pertinent signaling interactions and in vivo studies to define the role of these anti-apoptotic signaling pathways in the development of fibrotic lung disease. Our specific aims are: 1) to investigate the specific molecular mechanisms by which TGF-beta1 promotes autocrine activation of the pro-survival/anti-apoptotic PI3K/Akt signaling pathway in human lung fibroblasts, 2) to investigate the role of TGF-beta1 induced PI3K/Akt and FAK activation in the modulation and prevention of fibroblast apoptosis/anoikis, and 3) to examine, in vivo, the role of fibroblast-specific Akt activation in a murine model of pulmonary fibrosis. Collectively, these studies will provide important mechanistic insights into the cellular signaling pathways utilized by TGF-beta1 to regulate mesenchymal cell survival.
描述(由申请人提供):
该赠款提出了一项为期五年的培训计划,旨在促进作为医师科学家独立调查生涯的发展。 除了完成以下概述的研究外,该计划的目标还旨在提供学术独立所必需的指导,技术技能,实验室管理技能和知识基础。肺纤维化是进行性的,令人衰弱的过程,没有有效的治疗。 纤维化疾病的发病机理涉及功能失调的修复反应,其特征是与肌纤维细胞活性增强有关的上皮细胞损伤。成纤维细胞/成肌纤维细胞细胞凋亡是正常伤口愈合的关键组成部分,成纤维细胞失败会导致病理疤痕形成和组织纤维化。 促进纤维化疾病中抗凋亡间充质细胞表型的机制尚不清楚。 转化生长因子-BETA 1(TGF-BETA1)是一种以细胞类型和上下文特异性方式作用的多功能细胞因子。 通过刺激间充质细胞分化,激活和存活,TGF-BETA1对于大多数器官系统中纤维化疾病的发病机理至关重要。我们假设TGF-BETA1通过促进人肺间充质细胞中的抗凋亡表型来促进纤维化疾病的发病机理。 我们建议研究TGF-BETA1通过使用体外研究组合来保护间充质细胞免受凋亡的机制,以定义相关信号相互作用和体内研究,以定义这些抗凋亡信号通路在纤维化肺部发育中的作用。 我们的具体目的是:1)调查TGF-BETA1促进促溶性/抗凋亡PI3K/AKT信号途径的特定分子机制,在人类肺成纤维细胞中,2)以调查TGF-BETA1诱导的PI3K/AKT和FAK ACTRONTION的作用。凋亡/Anoikis和3)在体内检查成纤维细胞特异性AKT激活在肺纤维化模型中的作用。 总的来说,这些研究将为TGF-BETA1使用的细胞信号传导途径提供重要的机械见解,以调节间充质细胞的存活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey C Horowitz其他文献
Jeffrey C Horowitz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey C Horowitz', 18)}}的其他基金
X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung Fibrosis
成纤维细胞表型和肺纤维化中的 X 连锁凋亡抑制剂
- 批准号:
10094234 - 财政年份:2018
- 资助金额:
$ 13.21万 - 项目类别:
X-Linked Inhibitor of Apoptosis in Fibroblast Phenotypes and Lung Fibrosis
成纤维细胞表型和肺纤维化中的 X 连锁凋亡抑制剂
- 批准号:
10076125 - 财政年份:2018
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness
通过细胞外基质硬度确定间充质细胞的命运
- 批准号:
8501654 - 财政年份:2011
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness
通过细胞外基质硬度确定间充质细胞的命运
- 批准号:
8874259 - 财政年份:2011
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness
通过细胞外基质硬度确定间充质细胞的命运
- 批准号:
8183863 - 财政年份:2011
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness
通过细胞外基质硬度确定间充质细胞的命运
- 批准号:
8307799 - 财政年份:2011
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Fate Determination by Extracellular Matrix Stiffness
通过细胞外基质硬度确定间充质细胞的命运
- 批准号:
8680326 - 财政年份:2011
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Survival Signalling by TGF-B1
TGF-B1 的间充质细胞存活信号传导
- 批准号:
7478485 - 财政年份:2005
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Survival Signalling by TGF-B1
TGF-B1 的间充质细胞存活信号传导
- 批准号:
6956245 - 财政年份:2005
- 资助金额:
$ 13.21万 - 项目类别:
Mesenchymal Cell Survival Signalling by TGF-B1
TGF-B1 的间充质细胞存活信号传导
- 批准号:
7663866 - 财政年份:2005
- 资助金额:
$ 13.21万 - 项目类别:
相似国自然基金
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Mechanisms of tumor cell clustering in breast cancer metastasis
肿瘤细胞聚集在乳腺癌转移中的机制
- 批准号:
10744976 - 财政年份:2023
- 资助金额:
$ 13.21万 - 项目类别:
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
通过 APJ 抑制靶向卵巢癌球体形成和代谢适应
- 批准号:
10366717 - 财政年份:2021
- 资助金额:
$ 13.21万 - 项目类别:
Engineering a dynamic three-dimensional in vitro platform for the investigation of human Type 1 Diabetes immunopathogenesis
设计用于研究人类 1 型糖尿病免疫发病机制的动态三维体外平台
- 批准号:
10677617 - 财政年份:2021
- 资助金额:
$ 13.21万 - 项目类别:
Engineering a dynamic three-dimensional in vitro platform for the investigation of human Type 1 Diabetes immunopathogenesis
设计用于研究人类 1 型糖尿病免疫发病机制的动态三维体外平台
- 批准号:
10460123 - 财政年份:2021
- 资助金额:
$ 13.21万 - 项目类别:
Targeting ovarian cancer spheroid formation and metabolic adaptation by APJ inhibition
通过 APJ 抑制靶向卵巢癌球体形成和代谢适应
- 批准号:
10528490 - 财政年份:2021
- 资助金额:
$ 13.21万 - 项目类别: